Heparin-conjugated scaffolds with pore structure of inverted colloidal crystals for cartilage regeneration

Colloids and Surfaces B: Biointerfaces

Volumn 82, Issue 2, 2011, Pages 616-623

  Kuo, Yung Chih ^a   Tsai, Yu Tai ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Cartilage; Chondrogenesis; Heparin; Inverted colloidal crystal; Scaffold

Indexed keywords

BOVINE KNEE CHONDROCYTES; CARTILAGE REGENERATION; CHONDROCYTES; CHONDROGENESIS; COLLOIDAL CRYSTALS; COLLOIDAL TEMPLATES; CORE REGION; CRITICAL ISSUES; DE NOVO PRODUCTION; GLYCOSAMINOGLYCANS; HEPARIN; HEXAGONAL ARRAYS; IMMUNOCHEMICAL STAINING; MONO-DISPERSED; NEOCARTILAGE; POLYSTYRENE MICRO-SPHERE; SELF-ASSEMBLED; TYPE II COLLAGENS; UNIFORM DISTRIBUTION; WEIGHT PERCENTAGES;

BODY FLUIDS; CARTILAGE; COLLAGEN; CRYSTAL STRUCTURE; ETHYLENE; ETHYLENE GLYCOL; ORGANIC POLYMERS; POLYSACCHARIDES; POLYSTYRENES;

SCAFFOLDS;

COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN; HEPARIN; MICROSPHERE; POLYSTYRENE; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE SYNTHESIS; CARTILAGE CELL; CELL COMPOSITION; CELL VIABILITY; CELLULAR DISTRIBUTION; CHONDROGENESIS; COLLAGEN SYNTHESIS; COLLOID; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; CRYSTAL STRUCTURE; CULTURE MEDIUM; EXTRACELLULAR MATRIX; INCUBATION TIME; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; REACTION TIME; TISSUE ENGINEERING;

ANIMALS; CARTILAGE; CATTLE; CHITIN; CHONDROCYTES; COLLOIDS; CRYSTALLIZATION; ETHYLENE GLYCOL; GLYCOSAMINOGLYCANS; HEPARIN; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; POLYSTYRENES; TISSUE ENGINEERING;

BOVINAE;

EID: 78649446798     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.10.031     Document Type: Article

References (47)

1. Hosseinkhani H., Hosseinkhani M., Khademhosseini A., Kobayashi H. Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J. Control. Release 2007, 117:380-386.
2. Chang K.Y., Cheng L.W., Ho G.H., Huang Y.P., Lee Y.D. Fabrication and characterization of poly(γ-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering. Acta Biomater. 2009, 5:1937-1947.
3. Kuo Y.C., Lin C.Y. Effect of genipin-crosslinked chitin-chitosan scaffolds with hydroxyapatite modifications on the cultivation of bovine knee chondrocytes. Biotechnol. Bioeng. 2006, 95:132-144.
4. Kuo Y.C., Ku I.N. Effects of gel concentration, human fibronectin, and cation supplement on the tissue-engineered cartilage. Biotechnol. Prog. 2007, 23:238-245.
5. Kuo Y.C., Ku I.N. Cartilage regeneration by novel polyethylene oxide/chitin/chitosan scaffolds. Biomacromolecules 2008, 9:2662-2669.
6. Kuo Y.C., Ku I.N. Application of polyethyleneimine-modified scaffolds to the regeneration of cartilaginous tissue. Biotechnol. Prog. 2009, 25:1459-1467.
7. Kuo Y.C., Wang C.C. Effect of bovine pituitary extract on the formation of neocartilage in chitosan/gelatin scaffolds. J. Taiwan Inst. Chem. Eng. 2010, 41:150-156.
8. Kuo Y.C., Tsai Y.T. Inverted colloidal crystal scaffolds for uniform cartilage regeneration. Biomacromolecules 2010, 11:731-739.
9. Tian F., Hosseinkhani H., Hosseinkhani M., Khademhosseini A., Yokoyama Y., Estrada G.G., Kobayashi H. Quantitative analysis of cell adhesion on aligned micro- and nanofibers. J. Biomed. Mater. Res. A 2008, 84:291-299.
10. Kuo Y.C., Chung C.Y. Application of bovine pituitary extract and polyglycolide/poly(lactide-co-glycolide) scaffold to the cultivation of bovine knee chondrocytes. Biotechnol. Prog. 2005, 21:1708-1715.
11. Kuo Y.C., Leou S.N. Effects of composition, solvent, and salt particle on the physicochemical properties of polyglycolide/poly(lactide-co-glycolide) scaffolds. Biotechnol. Prog. 2006, 22:1664-1670.
12. Kuo Y.C., Hsu Y.R. Tissue-engineered polyethylene oxide/chitosan scaffolds as potential substitutes for articular cartilage. J. Biomed. Mater. Res. A. 2009, 91:277-287.
13. Yang S., Leong K.F., Du Z., Chua C.K. The design of scaffolds for use in tissue engineering: rapid prototyping techniques. Tissue Eng. 2002, 8:1-11.
14. Botchwey E.A., Dupree M.A., Pollack S.R., Levine E.M., Laurencin C.T. Tissue engineered bone: measurement of nutrient transport in three-dimensional matrices. J. Biomed. Mater. Res. 2003, 67A:357-367.
15. Stein A., Schroden R.C. Colloidal crystal templating of three-dimensionally ordered macroporous solids: materials for photonics and beyond. Curr. Opin. Solid State Mater. Sci. 2001, 5:553-564.
16. Velev O.D., Kaler E.W. Structured porous materials via colloidal crystal templating: from inorganic oxides to metals. Adv. Mater. 2000, 12:531-534.
17. Xia Y., Gates B., Yin Y., Lu Y. Monodispersed colloidal spheres: old materials with new applications. Adv. Mater. 2000, 12:693-713.
18. Shanbhag S., Leeb J.W., Kotov N. Diffusion in three-dimensionally ordered scaffolds with inverted colloidal crystal geometry. Biomaterials 2005, 26:5581-5585.
19. Kotov N.A., Liu Y., Wang S., Cumming C., Eghtedari M., Vargas G., Motamedi M., Nichols J., Cortiella J. Inverted colloidal crystals as three-dimensional cell scaffolds. Langmuir 2004, 20:7887-7892.
20. Zhang Y., Wang S., Eghtedari M., Motamedi M., Kotov N.A. Inverted colloidal crystals hydrogel matrices as three dimensional cell scaffold. Adv. Funct. Mater. 2005, 15:725-731.
21. Biondi M., Ungaro F., Quaglia F., Netti P.A. Controlled drug delivery in tissue engineering. Adv. Drug Deliv. Rev. 2008, 60:229-242.
22. Taylor S.J., McDonald J.W., Sakiyama-Elbert S.E. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J. Control. Release 2004, 98:281-294.
23. Sakiyama-Elbert S.E., Hubbell J.A. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J. Control. Release 2000, 65:389-402.
24. Cushing M.C., Liao J.T., Anseth K.S. Activation of valvular interstitial cells is mediated by transforming growth factor-β1 interactions with matrix molecules. Matrix Biol. 2005, 24:428-437.
25. Pufe T., Groth G., Goldring M.B., Tillmann B., Mentlein R. Effects of pleiotrophin, a heparin-binding growth factor, on human primary and immortalized chondrocytes. Osteoarthritis Cartilage 2007, 15:155-162.
26. Freeman I, Kedem A., Cohen S. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 2008, 29:3260-3268.
27. Rajangam K., Arnold M.S., Rocco M.A., Stupp S.I. Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity. Biomaterials 2008, 29:3298-3305.
28. Wissink M.J., Beernink R., Pieper J.S., Poot A.A., Engbers G.H., Beugeling T., van Aken W.G., Feijen J. Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials 2001, 22:2291-2299.
29. Yoon J.J., Chung H.J., Lee H.J., Park T.G. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J. Biomed. Mater. Res. A 2006, 79:934-942.
30. Jeon O., Song S.J., Kang S.W., Putnam A.J., Kim B.S. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold. Biomaterials 2007, 28:2763-2771.
31. Nillesen S.T., Geutjes P.J., Wismans R., Schalkwijk J., Daamen W.F., van Kuppevelt T.H. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 2007, 28:1123-1131.
32. van der Kraan P.M., Buma P., van Kuppevelt T., van den Berg W.B. Interaction of chondrocytes, extracellular matrix and growth factors: relevance for articular cartilage tissue engineering. Osteoarthritis Cartilage 2002, 10:631-637.
33. Sams A.E, Nixon A.J. Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects. Osteoarthritis Cartilage 1995, 3:47-59.
34. Boumediene K., Takigawa M., Pujol J.P. Cell density-dependent proliferative effects of transforming growth factor (TGF)-β1, β2, and β3 in human chondrosarcoma cells HCS-2/8 are associated with changes in the expression of TGF-β receptor type I. Cancer Invest. 2001, 19:475-486.
35. Freed L.E, Vunjak-Novakovic G., Biron R.J., Eagles D., Lesnoy D., Barlow S.K., Langer R. Biodegradable polymer scaffolds for tissue engineering. Biotechnology 1994, 20:689-693.
36. Hollander A.P., Heathfield T.F., Webber C., Iwata Y., Bourne R., Rorabeck C., Poole R.A. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J. Clin. Invest. 1994, 93:1722-1732.
37. Velev O.D., Lenhoff A.M. Colloidal crystals as templates for porous materials. Curr. Opin. Colloid Interface Sci. 2000, 5:56-63.
38. Hutmacher D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21:2529-2543.
39. Wang T., Turhan M., Gunasekaran S. Selected properties of pH-sensitive, biodegradable chitosan-poly(vinyl alcohol) hydrogel. Polym. Int. 2004, 53:911-918.
40. Tangsadthakun C., Kanokpanont S., Sanchavanakit N., Pichyangkura R., Banaprasert T., Tabata Y., Damrongsakkul S. The influence of molecular weight of chitosan on the physical and biological properties of collagen/chitosan scaffolds. J. Biomater. Sci. Polym. Ed. 2007, 18:147-163.
41. Rudd T.R., Skidmore M.A., Guimond S.E., Guerrini M., Cosentino C., Edge R., Brown A., Clarke D.T., Torri G., Turnbull J.E., Nichols R.J., Fernig D.G., Yates E.A. Site-specific interactions of copper(II) ions with heparin revealed with complementary (SRCD, NMR, FTIR and EPR) spectroscopic techniques. Carbohydr. Res. 2008, 343:2184-2193.
42. Fischer T.H., Connolly R., Thatte H.S., Schwaitzberg S.S. Comparison of structural and hemostatic properties of the poly-n-acetyl glucosamine Syvek Patch with products containing chitosan. Microsc. Res. Technol. 2004, 63:168-174.
43. Yang T., Hussain A., Bai S., Khalil I.A., Harashima H., Ahsan F. Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin. J. Control. Release 2006, 115:289-297.
44. Guaccio A., Borselli C., Oliviero O., Netti P.A. Oxygen consumption of chondrocytes in agarose and collagen gels: a comparative analysis. Biomaterials 2008, 29:1484-1493.
45. Lu Q., Zhang S., Hu K., Feng Q., Cao C., Cui F. Cytocompatibility and blood compatibility of multifunctional fibroin/collagen/heparin scaffolds. Biomaterials 2007, 28:2306-2313.
46. El Khoury R., Misra V., Sharma S., Cox C.S., Walker P., Grotta J.C., Gee A., Suzuki S., Savitz S.I. The effect of transcatheter injections on cell viability and cytokine release of mononuclear cells. Am. J. Neuroradiol. 2010, 31:1488-1492.
47. Eidi H., Joubert O., Attik G., Duval R.E., Bottin M.C., Hamouia A., Maincent P., Rihn B.H. Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages. Int. J. Pharm. 2010, 396:156-165.